Reprise Biomedical’s Miro3D Wound Matrix Granted Level II HCPCS Code by CMS
MINNEAPOLIS, Minnesota—Reprise Biomedical, Inc., an innovator in medical biotechnology for wound care, announced the Centers for Medicare and Medicaid Services (CMS) has assigned a Level II Healthcare Common Procedure Coding System (HCPCS) code to its Miro3D wound matrix, effective Oct. 1, 2023.
Post navigation
OUR DIGITAL PARTNERS


